SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q3 2025

Type / Class
Equity / Common Stock, par value $.0001 per share
Symbol
SWTX
Shares outstanding
75,607,738
Price per share
$47.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
45,321
Total reported value
$2,391,055
% of total 13F portfolios
0%
Share change
-74,988,790
Value change
-$3,523,805,946
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 9.6% $331,026,195 7,158,871 The Vanguard Group 31 Dec 2024
Hudson Bay Capital Management LP 5.2% $184,992,910 3,936,857 Hudson Bay Capital Management LP 30 Jun 2025
Deep Track Capital, LP 4.6% $160,025,357 3,460,756 Deep Track Capital, LP 31 Dec 2024
FMR LLC 1.7% $58,187,769 1,258,386 FMR LLC 30 Apr 2025
GOLDMAN SACHS GROUP INC 0% -93% $7,115 -$228,207,264 132 -100% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

As of 30 Sep 2025, 4 institutional investors reported holding 45,321 shares of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX). This represents 0.06% of the company’s total 75,607,738 outstanding shares.

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 45,321 $2,391,055 -$3,523,805,946 $46.99 4
2025 Q2 75,052,336 $3,527,065,482 +$106,385,453 $46.99 221
2025 Q1 73,697,303 $3,254,809,380 -$236,161,841 $44.13 304
2024 Q4 80,867,369 $2,921,793,248 -$118,091,155 $36.13 214
2024 Q3 80,746,495 $2,587,723,334 +$49,338,074 $32.04 224
2024 Q2 77,131,944 $2,905,842,857 -$85,605,108 $37.67 207
2024 Q1 78,252,813 $3,851,696,232 +$167,390,016 $49.22 215
2023 Q4 75,361,544 $2,751,027,541 +$377,734,473 $36.50 177
2023 Q3 68,463,334 $1,579,882,169 -$32,327,366 $23.12 146
2023 Q2 69,628,559 $1,822,205,095 +$89,779,420 $26.22 140
2023 Q1 66,260,215 $1,702,158,459 -$5,021,341 $25.74 146
2022 Q4 66,570,883 $1,728,050,586 +$78,211,361 $26.01 136
2022 Q3 63,366,577 $1,801,775,442 +$234,357,441 $28.53 143
2022 Q2 55,292,284 $1,362,389,164 +$60,440,902 $24.62 138
2022 Q1 49,432,959 $2,790,521,874 +$222,890,732 $56.44 131
2021 Q4 45,453,187 $2,817,721,092 +$26,758,911 $61.98 141
2021 Q3 45,080,155 $2,861,165,390 +$40,050,823 $63.44 139
2021 Q2 44,740,163 $3,687,111,174 +$75,214,918 $82.41 133
2021 Q1 43,923,797 $3,231,236,494 +$39,655,480 $73.57 135
2020 Q4 43,386,194 $3,146,822,308 +$421,342,946 $72.52 123
2020 Q3 37,429,094 $1,784,359,599 +$128,329,715 $47.67 91
2020 Q2 34,753,276 $1,459,633,432 +$82,304,857 $42.00 77
2020 Q1 32,985,223 $890,602,797 +$24,755,483 $27.00 68
2019 Q4 31,922,184 $1,228,678,977 +$28,086,854 $38.49 56
2019 Q3 31,217,200 $676,785,000 +$676,785,000 $21.68 43
2019 Q2 53,948 $4,446,000 $82.41 1
2019 Q1 53,948 $4,446,000 $82.41 1